SRPT SAREPTA THERAPEUTICS INC

2026Q1 · CUSIP 803607100 · Sector: Healthcare & Biotech

Danger · Dual-confirm: breadth + price

Holders

341

Δ holders QoQ

-8

Breadth percentile

Top 83%

Whale holders

167

Δ whales

Inst. holding value

$2.2B

New positions

Closed positions

Price momentum (1Q)

-4.9%

Put / Call

15/13

Breadth history (34 quarters)

Past Lit Events & Aftermath 14 lit events

Period	Percentile	Next-1Q return	Next-2Q return
2025Q4	Top 17%	-4.9%	—
2024Q2	Top 1%	-18.2%	-19.7%
2024Q1	Top 17%	+4.5%	-20.4%
2023Q1	Top 13%	-25.4%	-43.7%
2022Q4	Top 10%	+20.0%	-8.3%
2022Q3	Top 1%	+14.0%	+36.5%
2021Q4	Top 13%	-14.4%	+35.8%
2020Q4	Top 12%	-17.3%	-15.8%
2020Q2	Top 6%	-10.9%	-43.5%
2019Q4	Top 8%	+19.5%	+29.3%
2019Q1	Top 6%	+2.7%	-19.9%
2018Q3	Top 8%	+14.7%	+2.2%
2018Q2	Top 3%	-13.6%	+8.2%
2018Q1	Top 10%	+41.1%	+21.9%

Show all 14 events

Options Sentiment

Put holders

QoQ: -4

Call holders

QoQ: -9

See methodology →

Fundamentals

PE (TTM)

50.6

EPS (TTM)

$0.34

EPS YoY

—

Revenue (TTM)

$2.2B

Revenue YoY

-2.2%

Net margin

3.0%

ROE

4.3%

Debt ratio

52.6%

FCF (TTM)

$115M

Dividend (TTM)

No dividend

Quarterly Revenue & EPS (4Y)

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)

Get the next update

2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.